Total Payments
$5,071
2023 Payments
$1,044
Companies
36
Transactions
280
Medicare Patients
981
Medicare Billing
$53,475
Payment Breakdown by Category
Food & Beverage$5,071 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,071 | 280 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $561.73 | 34 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $545.32 | 32 | $0 (2023) |
| Lilly USA, LLC | $544.24 | 39 | $0 (2023) |
| ABBVIE INC. | $501.04 | 29 | $0 (2023) |
| GlaxoSmithKline, LLC. | $406.07 | 17 | $0 (2023) |
| PFIZER INC. | $266.64 | 16 | $0 (2023) |
| Amarin Pharma Inc. | $261.74 | 12 | $0 (2022) |
| Amgen Inc. | $253.84 | 11 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $183.92 | 7 | $0 (2022) |
| UPSHER-SMITH LABORATORIES LLC | $160.81 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,044 | 61 | Novo Nordisk Inc ($176.50) |
| 2022 | $2,422 | 136 | Novo Nordisk Inc ($385.23) |
| 2021 | $1,605 | 83 | GlaxoSmithKline, LLC. ($212.87) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/30/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: PAIN | ||||||
| 05/31/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Diabetes | ||||||
| 05/27/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Urology | ||||||
| 05/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Diabetes | ||||||
| 05/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Diabetes | ||||||
| 05/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes | ||||||
| 05/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Inflammation | ||||||
| 05/05/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/05/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: DIABETES | ||||||
| 05/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Gastroenterology | ||||||
| 05/03/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: Diabetes | ||||||
| 04/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Obesity | ||||||
| 04/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Cardio-renal | ||||||
| 04/27/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: Diabetes | ||||||
| 04/26/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Urology | ||||||
| 04/21/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Endocrinology | ||||||
| 04/19/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $23.19 | General |
| Category: Sleep | ||||||
| 04/13/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 04/04/2023 | UPSHER-SMITH LABORATORIES LLC | ZEMBRACE SYMTOUCH (Drug), TOSYMRA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROLOGY | ||||||
| 04/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 445 | 676 | $110,410 | $19,088 |
| 2022 | 11 | 288 | 482 | $77,137 | $18,095 |
| 2021 | 10 | 221 | 333 | $54,399 | $14,879 |
| 2020 | 2 | 27 | 30 | $4,255 | $1,413 |
Total Patients
981
Total Services
1,521
Medicare Billing
$53,475
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 139 | $57,715 | $10,157 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 67 | $19,817 | $3,469 | 17.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $8,800 | $2,075 | 23.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 51 | $3,954 | $423.53 | 10.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 26 | 26 | $2,084 | $408.20 | 19.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 17 | 19 | $1,801 | $368.96 | 20.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 11 | 11 | $2,523 | $358.16 | 14.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 36 | $2,100 | $342.72 | 16.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $1,020 | $336.93 | 33.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $1,824 | $336.93 | 18.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $1,433 | $282.60 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 39 | $2,996 | $248.96 | 8.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 24 | 27 | $1,287 | $157.58 | 12.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 49 | 50 | $779.00 | $110.00 | 14.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 32 | 152 | $2,277 | $12.84 | 0.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 172 | $54,180 | $13,260 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 49 | $10,535 | $2,768 | 26.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 15 | 17 | $2,312 | $733.81 | 31.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 43 | $3,225 | $364.63 | 11.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 11 | 12 | $1,200 | $259.54 | 21.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 15 | 24 | $1,080 | $230.24 | 21.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 11 | 11 | $605.00 | $178.05 | 29.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 22 | $1,540 | $172.47 | 11.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 15 | 16 | $240.00 | $75.11 | 31.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 20 | $300.00 | $44.35 | 14.8% |
About Delara Pollman, APRN-CNP
Delara Pollman, APRN-CNP is a Family healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1962766303.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Delara Pollman, APRN-CNP has received a total of $5,071 in payments from pharmaceutical and medical device companies, with $1,044 received in 2023. These payments were reported across 280 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,071).
As a Medicare-enrolled provider, Pollman has provided services to 981 Medicare beneficiaries, totaling 1,521 services with total Medicare billing of $53,475. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Irving, TX
- Active Since 06/29/2012
- Last Updated 10/03/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1962766303
Products in Payments
- TRELEGY ELLIPTA (Drug) $278.78
- Vascepa (Drug) $261.74
- NURTEC ODT (Drug) $260.01
- Rybelsus (Drug) $252.97
- FARXIGA (Drug) $248.42
- BREZTRI (Drug) $246.37
- VRAYLAR (Drug) $235.61
- TRULICITY (Drug) $207.79
- EMGALITY (Drug) $153.44
- Kerendia (Drug) $150.98
- Ozempic (Drug) $140.68
- UBRELVY (Drug) $138.33
- Aimovig (Biological) $135.64
- MOUNJARO (Drug) $133.77
- XIFAXAN (Drug) $129.01
- SHINGRIX (Biological) $127.29
- JARDIANCE (Drug) $118.91
- REXULTI (Drug) $114.50
- Dexcom G6 Transmitter (Medical Supply) $114.45
- Myrbetriq (Drug) $98.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Irving
Kierra Smith
Family — Payments: $4,393
Family $4,393
Ranbir Sidhu
Family — Payments: $3,550
Family $3,550
Sigimol Joseph, Fnp, FNP
Family — Payments: $3,362
Family $3,362
Consuelo Alanis, Msn, Aprn, Fnp-Bc, MSN, APRN, FNP-BC
Family — Payments: $3,071
Family $3,071
Alexandra Clark, Anp, ANP
Family — Payments: $2,597
Family $2,597
Elise Woodside, Fnp-Bc, FNP-BC
Family — Payments: $2,058
Family $2,058